EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a patient decision aid prototype on the decision to continue, reduce or discontinue antipsychotic medication following remission of first-episode psychosis

Laurent Béchard iD, Olivier Corbeil iD, Maxime Huot-Lavoie, Olivier Roy, Sébastien Brodeur iD, Emmanuelle Bouchard, Joanne Martel, Natalie Pavey, Amélie M Achim, Matthew Menear, Marc-André Roy, Sophie Lauzier und 1 weitere

BJPsych Open · 2026-05 · 12 (3)

DOI: 10.1192/bjo.2026.11034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJPsych Open, online erschienen am 06.05.2026. Verfasst von Laurent Béchard und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Nursing, https://ror.org/04sjchr03Université Laval, Quebec, Canada. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Shared decision-making is essential to patient-centred care, but remains underutilised in psychiatry, particularly when deciding whether to continue, reduce or stop antipsychotic medication after remission from first-episode psychosis (FEP). Existing decision aids do not fully address recovery goals such as autonomy, identity and social reintegration.

Aims

To co-develop a patient decision aid (PDA) prototype that supports individuals in making the decision to continue, reduce or stop antipsychotics following remission from FEP.

Method

We used a patient-centred design process informed by International Patient Decision Aid Standards (IPDAS), User Centered Design (UCD-11) and the CHIME framework. A multidisciplinary steering group – including individuals with lived experience, clinicians, and researchers – co-developed the PDA. Iterative feedback was collected from an external advisory group of patient partners, caregivers and healthcare providers ( n = 7). Acceptability was evaluated with structured questionnaires.

Results

The final prototype, structured into five sections (decision overview, personal values, risks and benefits, planning and real-life experiences), demonstrated strong acceptability across stakeholders. Ratings improved with each iteration, with version 3 receiving near-perfect scores on clarity, usefulness and balance. Users described the tool as relatable and empowering. The inclusion of real-life stories and visual decision exercises were particularly valued. However, some clinicians expressed concerns about time constraints and workflow integration.

Conclusions

This recovery-oriented PDA prototype offers a practical, evidence-based resource to facilitate shared decision-making with respect to continuing, reducing or stopping antipsychotics after FEP. Although early feedback is promising, pilot testing is needed to evaluate its impact on decision quality, satisfaction and treatment outcomes.

Schlagwörter

Stichwörter der Autor:innen

Decision aidantipsychoticspsychosisrecoveryshared decision making

Autor:innen und Institutionen

  • Faculty of Nursing, https://ror.org/04sjchr03Université Laval, Quebec, Canada.
  • Faculty of Pharmacy, https://ror.org/04sjchr03Université Laval, Quebec, Canada.
  • Quebec Mental Health University Institute, CIUSSS-CN, Quebec, Canada.
  • CERVO Brain Research Centre, Quebec, Canada.
  • Department of Psychiatry and Neurosciences, Faculty of Medicine, Université Laval, Quebec, Canada.
  • Department of Health Sciences, Université du Québec à Rimouski, Quebec, Canada.

ORCID-Profile: Laurent Béchard, Olivier Corbeil, Sébastien Brodeur

Zitieren

APA

Béchard, L., Corbeil, O., Huot-Lavoie, M., Roy, O., Brodeur, S., Bouchard, E., Martel, J., Pavey, N., Achim, A. M., Menear, M., Roy, M. A., Lauzier, S., & Demers, M. F. (2026). Development of a patient decision aid prototype on the decision to continue, reduce or discontinue antipsychotic medication following remission of first-episode psychosis. BJPsych Open, 12(3). https://doi.org/10.1192/bjo.2026.11034

Vancouver

Béchard L, Corbeil O, Huot-Lavoie M, Roy O, Brodeur S, Bouchard E, et al. Development of a patient decision aid prototype on the decision to continue, reduce or discontinue antipsychotic medication following remission of first-episode psychosis. BJPsych Open. 2026;12(3). doi:10.1192/bjo.2026.11034

BibTeX
@article{Bchard2026,
  author = {Béchard, Laurent and Corbeil, Olivier and Huot-Lavoie, Maxime and Roy, Olivier and Brodeur, Sébastien and Bouchard, Emmanuelle and Martel, Joanne and Pavey, Natalie and Achim, Amélie M and Menear, Matthew and Roy, Marc-André and Lauzier, Sophie and Demers, Marie-France},
  title = {Development of a patient decision aid prototype on the decision to continue, reduce or discontinue antipsychotic medication following remission of first-episode psychosis},
  journal = {BJPsych Open},
  year = {2026},
  volume = {12},
  number = {3},
  doi = {10.1192/bjo.2026.11034}
}
Kostenlos starten →